Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 12, 2007. The report serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change reported is the acquisition of Ordinary shares by four specific individuals under the Company's ShareReward Plan on September 11, 2007. The shares were purchased at a price of GBP 13.15 per share.
- Mr J S Heslop: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr R Bondy: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr D Learmouth: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr A P Witty: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transactions described above in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: September 11, 2007.
- Share Price: GBP 13.15 per Ordinary share.
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.
- Participants: Four senior individuals (Heslop, Bondy, Learmouth, Witty) each acquired a total of 18 shares (9 personal, 9 matched).
- Notification Date: September 12, 2007.